These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. 1-hydroxyPGE reduces infarction volume in mouse transient cerebral ischemia. Ahmad M; Saleem S; Zhuang H; Ahmad AS; Echeverria V; Sapirstein A; Doré S Eur J Neurosci; 2006 Jan; 23(1):35-42. PubMed ID: 16420413 [TBL] [Abstract][Full Text] [Related]
30. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway. Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734 [TBL] [Abstract][Full Text] [Related]
31. Role of PDE3B in insulin-induced glucose uptake, GLUT-4 translocation and lipogenesis in primary rat adipocytes. Zmuda-Trzebiatowska E; Oknianska A; Manganiello V; Degerman E Cell Signal; 2006 Mar; 18(3):382-90. PubMed ID: 15961276 [TBL] [Abstract][Full Text] [Related]
32. Progesterone secretion by luteinizing human granulosa cells: a possible cAMP-dependent but PKA-independent mechanism involved in its regulation. Chin EC; Abayasekara DR J Endocrinol; 2004 Oct; 183(1):51-60. PubMed ID: 15525573 [TBL] [Abstract][Full Text] [Related]
33. Prostaglandin E2-mediated anabolic effect of a novel inhibitor of phosphodiesterase 4, XT-611, in the in vitro bone marrow culture. Miyamoto K; Suzuki H; Yamamoto S; Saitoh Y; Ochiai E; Moritani S; Yokogawa K; Waki Y; Kasugai S; Sawanishi H; Yamagami H J Bone Miner Res; 2003 Aug; 18(8):1471-7. PubMed ID: 12929936 [TBL] [Abstract][Full Text] [Related]
34. Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase. Kilic E; Kilic U; Matter CM; Lüscher TF; Bassetti CL; Hermann DM Stroke; 2005 Feb; 36(2):332-6. PubMed ID: 15625301 [TBL] [Abstract][Full Text] [Related]
35. Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries. Birk S; Edvinsson L; Olesen J; Kruuse C Eur J Pharmacol; 2004 Apr; 489(1-2):93-100. PubMed ID: 15063160 [TBL] [Abstract][Full Text] [Related]
36. Neuroprotective role of angiotensin II type 2 receptor after transient focal ischemia in mice brain. Miyamoto N; Zhang N; Tanaka R; Liu M; Hattori N; Urabe T Neurosci Res; 2008 Jul; 61(3):249-56. PubMed ID: 18455256 [TBL] [Abstract][Full Text] [Related]
37. Adrenomedullin deficiency and aging exacerbate ischemic white matter injury after prolonged cerebral hypoperfusion in mice. Mitome-Mishima Y; Miyamoto N; Tanaka R; Shimosawa T; Oishi H; Arai H; Hattori N; Urabe T Biomed Res Int; 2014; 2014():861632. PubMed ID: 25028667 [TBL] [Abstract][Full Text] [Related]
38. Infarct size limitation by adrenomedullin: protein kinase A but not PI3-kinase is linked to mitochondrial KCa channels. Nishida H; Sato T; Miyazaki M; Nakaya H Cardiovasc Res; 2008 Jan; 77(2):398-405. PubMed ID: 17706952 [TBL] [Abstract][Full Text] [Related]